百特国际 2025年季度报告

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. BAXTER INTERNATIONAL INC.FORM 10-QFor the quarterly period ended March31, 2025TABLE OF CONTENTS PART I.FINANCIAL INFORMATION Item 1.Financial Statements (unaudited) PART II.OTHER INFORMATIONItem 1.Legal ProceedingsItem 1A.Risk FactorsItem 2.Unregistered Sales of Equity Securities and Use of ProceedsItem 5.Other InformationItem 6.ExhibitsSignature Baxter International Inc.Condensed Consolidated Statements of Changes in Equity (unaudited) Baxter International Inc. 1.BASIS OF PRESENTATION The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we,our or Baxter) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission(SEC) for interim financial reporting. Accordingly, certain information and note disclosures normally included in financialstatements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustmentsnecessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Allsuch adjustments, unless otherwise noted herein, are of a normal, recurring nature. The disclosures presented in our On August 12, 2024, we entered into an Equity Purchase Agreement (EPA) with certain affiliates of Carlyle Group Inc.(Carlyle) to sell our Kidney Care business. That business, which is now known as Vantive Health LLC (Vantive) iscomprised of our former Kidney Care segment and provides chronic and acute dialysis therapies and services, includingperitoneal dialysis, hemodialysis, continuous renal replacement therapies, and other organ support therapies. On January31, 2025, we completed the sale of our Kidney Care business to Carlyle for an aggregate purchase price of $3.80billion incash, subject to certain closing cash, working capital and debt adjustments. After giving effect to certain adjustments, we Hurricane Helene In September 2024, Hurricane Helene, which brought significant rain and extensive flooding to Western North Carolina,caused damage to certain of our assets at our North Cove facility in Marion, North Carolina and disrupted operations atthat facility. Since then, we have actively worked with customers, regulators and other stakeholders to manage inventoryand minimize disruption to patient care as we worked towards resuming our North Cove manufacturing operations. Whilewe continue to increase allocation levels across key impacted product groups, the facility was fully operational by the end Risks and Uncertainties Supply Constraints, Tariffs and Global Economic Conditions We have experienced significant challenges to our global supply chain, including production delays and interruptions,increased costs and shortages of raw materials and component parts (including resins and electromechanical devices),higher transportation costs, adverse impacts from significant weather events (including Hurricane Helene, which causedthe flooding of our North Cove facility), elevated inflation levels and interest rates, disruptions to certain ports of call andaccess to shipping ports around the world, the war in Ukraine, the conflict in the Middle East and other geopolitical events.While we have seen improvements in the availability of component parts and improved pricing in raw materials and on additional mitigation opportunities in 2025 and beyond, we currently expect that our results will be adversely affected(including as a result of a failure to achieve the anticipated offsets or an inability to identify additional mitigating actions).Additionally, continued global macroeconomic uncertainty, including in trade policies and practices, elevated tariffs and inoperational and policy changes in the governments of the U.S. and other countries, could contribute to further market We expect that these challenges, among other factors, may continue to have an adverse effect on our business. 2.DISCONTINUED OPERATIONS A component of an entity is reported in discontinued operations after meeting the criteria for held-for-sale classification ifthe disposition represents a strategic shift that has (or will have) a major effect on the entity's operations and financial Discontinued Operations - Kidney Care On January 31, 2025, we completed the sale of our Kidney Care business to Carlyle for an aggregate purchase price of$3.80billion in cash, subject to certain closing cash, working capital and debt adjustments. After giving effect to certainadjustments, we received app